Cleared Traditional

K152822 - VidiStar HeartView

K152822 is an FDA 510(k) clearance for VidiStar HeartView, manufactured by Vidistar, LLC. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 58-day FDA review.

K152822 · Vidistar, LLC · Radiology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Nov 2015
Decision
58d
Days
Class 2
Risk

K152822 is an FDA 510(k) clearance for the VidiStar HeartView. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Vidistar, LLC (Greenville, US). The FDA issued a Cleared decision on November 25, 2015 after a review of 58 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

FDA 510(k) Submission Details - K152822

510(k) Number K152822 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 28, 2015
Decision Date November 25, 2015
Days to Decision 58 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
49d faster than avg
Panel avg: 107d · This submission: 58d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Translational Science Solutions, LLC
KATHRYN BECKER

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 2241
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K152822.
Ez3D Plus
K152746 · Ewoosoft Co., Ltd. · Jan 2016
Econsole1
K152172 · DRTECH Corporation · Dec 2015
Implant Studio 2015
K152078 · 3Shape Medical A/S · Dec 2015
Philips IntelliSpace Cardiovascular
K153022 · Philips Medical Systems Nethrlands BV · Nov 2015
HICAT Air
K152661 · Hicat GmbH · Nov 2015
UroNav (Version 2.0)
K153073 · Invivo Corporation · Nov 2015